Nitin Kapoor

Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial

Katherine R. Tuttle, Sibylle J. Hauske, María Eugênia Fernandes Canziani et al. · The Lancet · 2023 · 151 citations · Full text

Hypertension, Renal Function, Renal Disease +10

Prevalence of normal weight obesity and its associated cardio-metabolic risk factors – Results from the baseline data of the Kerala Diabetes Prevention Program (KDPP)

Nitin Kapoor, Mojtaba Lotfaliany, Thirunavukkarasu Sathish et al. · PLoS ONE · 2020 · 95 citations · Full text

The Indian Society for Bone and Mineral Research (ISBMR) position statement for the diagnosis and treatment of osteoporosis in adults

Sanjay Kumar Bhadada, Manoj Chadha, Usha Sriram et al. · Archives of Osteoporosis · 2021 · 53 citations

Bone Disease, Rheumatology, Bone Health +10

Osteoporosis in Healthy South Indian Males and the Influence of Life Style Factors and Vitamin D Status on Bone Mineral Density

Sahana Shetty, Nitin Kapoor, Dukhabandhu Naik et al. · Journal of Osteoporosis · 2014 · 51 citations · Full text

Nutrition, Cardiometabolic Risk, Fracture Diagnostics +24

Body composition, metabolic characteristics, and insulin resistance in obese and nonobese women with polycystic ovary syndrome

ThomasV Paul, Anil Satyaraddi, KripaElizabeth Cherian et al. · Journal of Human Reproductive Sciences · 2019 · 51 citations · Full text